Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.390
+0.040 (2.96%)
At close: Apr 2, 2026, 4:00 PM EDT
1.370
-0.020 (-1.44%)
After-hours: Apr 2, 2026, 4:26 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $125.73 million as of April 2, 2026. Its market cap has decreased by -24.67% in one year.
Market Cap
125.73M
Enterprise Value
112.18M
1-Year Change
-24.67%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $125.73M, an increase of 0.41%. That is a compound annual growth rate of 0.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 125.73M | -27.48% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oramed Pharmaceuticals | 138.33M |
| Black Diamond Therapeutics | 136.92M |
| Karyopharm Therapeutics | 132.78M |
| Kalaris Therapeutics | 132.75M |
| Alpha Cognition | 130.02M |
| Agenus | 127.87M |
| Equillium | 124.56M |
| Sangamo Therapeutics | 124.32M |